TNYA · Tenaya Therapeutics, Inc.
$0.70
+0.01 (+0.98%)
At close · Aug 21
Market Cap
$156.36M
Shares
224.23M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Faraz Ali | M.B.A. Chief Executive Officer Whittemore (Whit) Tingley, M.D., Ph.D. | $1,881,396 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Faraz Ali | M.B.A. Whittemore (Whit) Tingley, M.D., Ph.D. | $3,281,901 |
| Leone D. Patterson | M.B.A. | $1,364,989 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Faraz Ali | M.B.A. Whittemore (Whit) Tingley, M.D., Ph.D. | $2,890,062 |
| Leone D. Patterson | M.B.A. | $1,273,581 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Faraz Ali | M.B.A. Whittemore (Whit) Tingley, M.D., Ph.D. | $5,567,400 |
| Timothy Hoey | Whittemore (Whit) Tingley, M.D., Ph.D. | $2,561,519 |
| Leone D. Patterson | — | $1,365,241 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Faraz Ali | M.B.A. | $4,970,756 |
| Leone D. Patterson | M.B.A. Whittemore (Whit) Tingley, M.D., Ph.D. | $1,697,258 |
| Timothy Hoey | Whittemore (Whit) Tingley, M.D., Ph.D. | $619,307 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Faraz Ali | M.B.A. | $750,300 |
| Leone D. Patterson | M.B.A. Whittemore (Whit) Tingley, M.D., Ph.D. | — |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Tomohiro Higa | acting interim Principal Accounting Officer | Resigned | 2026-06-29 |
| Faraz Ali | interim Principal Financial Officer | Resigned | 2026-06-29 |
| Eric Hyllengren | Chief Financial Officer | Appointed | 2026-06-29 |
| Catherine Stehman-Breen | Class II Director | Appointed | 2026-05-29 |
| Karah Parschauer | Class II Director | Appointed | 2026-05-29 |
| Amy Burroughs | Class II Director | Appointed | 2026-05-29 |
| David Goeddel | director | Resigned | 2026-01-02 |
| Tomohiro Higa | Interim Principal Accounting Officer | Appointed | 2025-02-07 |
| Chihiro Saito | Senior Vice President, Accounting and Financial Operations and Interim Principal Accounting Officer | Resigned | 2024-12-17 |
| Karah Parschauer | Class I director | Resigned | 2024-09-16 |
| Karah Parschauer | Class II director | Appointed | 2024-09-16 |
| Chihiro Saito | Interim Principal Accounting Officer (PAO) | Appointed | 2024-08-08 |
| Faraz Ali | Interim Principal Financial Officer (PFO) | Appointed | 2024-08-08 |
| Leone Patterson | Chief Financial and Business Officer | Resigned | 2024-07-25 |
| Jin-Long Chen | director | Resigned | 2024-06-27 |
| Amy Burroughs | Class II director | Appointed | 2022-12-07 |
| Eli Casdin | director | Resigned | 2022-12-07 |
| Karah Parschauer | Director | Appointed | 2021-12-22 |
| June Lee, M.D. | Class III director | Appointed | 2021-11-22 |
| JeenJoo Kang, Ph.D. | director | Resigned | 2021-11-22 |
Key facts
CIK
1858848
CUSIP
87990A106
13F (30d)
85 filings
85 filers
Visit website
Investor relations